Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy

THE ROLE OF BIOTRANSFORMATION ENZYMES IN THE DEVELOPMENT OF RENAL INJURY AND UROTHELIAL CANCER CAUSED BY ARISTOLOCHIC ACID: URGENT QUESTIONS AND DIFFICULT ANSWERS

(2012) Marie Stiborova et al.   BIOMEDICAL PAPERS-OLOMOUC

Regulation of CYP1A1 by heavy metals and consequences for drug metabolism

(2009) Anwar Anwar-Mohamed et al.   Expert Opinion on Drug Metabolism & Toxicology

Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

(2009) Eray Goekkurt et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of the Effect of MDR1 C3435T Polymorphism on Cyclosporine Pharmacokinetics

(2008) Zhi-Ping Jiang et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

CYP1A1, GSTM1, and GSTT1 Polymorphisms, Smoking, and Lung Cancer Risk in a Pooled Analysis among Asian Populations

(2008) K.-M. Lee et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer

(2008) João Paulo Souto Grando et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity

(2008) Y. Xiao et al.   KIDNEY INTERNATIONAL

Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy

(2007) Marie Stiborová et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH